http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2012504122-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-025
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F5-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K5-06078
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-50
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-69
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F5-04
filingDate 2009-09-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2012-02-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2012504122-A
titleOfInvention Derivatives of 1-amino-2-cyclobutylethylboronic acid
abstract The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases. For example, the present invention provides a pharmaceutical composition comprising a compound of the present invention and a pharmaceutically acceptable carrier. For example, according to the present invention, there is also provided a method for treating cancer comprising administering the pharmaceutical composition of the present invention to a patient in need of such treatment.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017536335-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018502048-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2018502049-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2017531646-A
priorityDate 2008-09-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H0291023-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007502304-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467567130
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465154993
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465154914
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466263177
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163560128
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465204167
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467166272
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID147851850
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467276007
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466008324
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409239761
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163560074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID467570987
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID465655998

Total number of triples: 55.